Zainab O. Atiq
Role not yet determined Is this you? Add your title
Also affiliated: Rhodes College (2018); Unity Health System (2021); Duke Medical Center (2021)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Zainab O. Atiq's research has focused on several areas within health sciences, including the mechanisms of drug-induced conditions and interactions within biological systems. She has investigated pembrolizumab-induced conditions such as distal renal tubular acidosis and cold agglutinin disease. Her work also includes the study of Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury and the characterization of protein kinase C domain interactions with the formin SepA in *Aspergillus nidulans*, which is involved in fungal growth and septation.
Additionally, Atiq has examined disparities among patients with genitourinary (GU) cancer referred to palliative care. Her scholarly output includes a case of metastatic pancreatic adenocarcinoma in complete remission using chemotherapy and immunotherapy. With an h-index of 5 and 47 total citations across 9 publications, her recent activity indicates ongoing engagement in medical research.
Metrics
- h-index: 5
- Publications: 8
- Citations: 38
Selected Publications
-
Disparities among GU cancer patients referred to palliative care. (2021)
-
A case of pembrolizumab induced distal renal tubular acidosis (2021)
-
A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy (2021)
-
Pembrolizumab-Induced Cold Agglutinin Disease (2020)
-
Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury (2020)
Collaboration Network
Top Collaborators
- A case of pembrolizumab induced distal renal tubular acidosis
- Pembrolizumab-Induced Cold Agglutinin Disease
- A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
- Disparities among GU cancer patients referred to palliative care.
- Pembrolizumab-Induced Cold Agglutinin Disease
- Pembrolizumab-Induced Cold Agglutinin Disease
- Pembrolizumab-Induced Cold Agglutinin Disease
- A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
- Pembrolizumab-Induced Cold Agglutinin Disease
- A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
- Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury
- Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury
- Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury
- Sirt2-associated transcriptome modifications in cisplatin-induced neuronal injury
- Pembrolizumab-Induced Cold Agglutinin Disease
- A Case of Metastatic Pancreatic Adenocarcinoma in Complete Remission Using Chemotherapy and Immunotherapy
- A case of pembrolizumab induced distal renal tubular acidosis
- A case of pembrolizumab induced distal renal tubular acidosis
- A case of pembrolizumab induced distal renal tubular acidosis
- Disparities among GU cancer patients referred to palliative care.
- Disparities among GU cancer patients referred to palliative care.
- Disparities among GU cancer patients referred to palliative care.
Similar Researchers
Based on overlapping research topics